By 2031 developing countries could need an estimated $35 billion to fight HIV/AIDS â€“ three times the amount currently spent, according to a Health Affairs study published Tuesday, the New York Times reports. The analysis â€“ based on economic models that assumed condoms, drugs and circumcision would be widespread – found that “even under the best case … more than one million people would be newly infected each year.
Access to Health Services
On Tuesday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, scientists and global health experts focused on malaria eradication, Agence France-Presse reports. “Key among the strategies … is the development of an effective anti-malaria vaccine, a project scientists have been researching since the late 80s. … RTS,S is the most clinically advanced malaria vaccine so far, according to the Malaria Vaccine Initiative,” the news service writes (11/3).
Also In Global Health News: Breast Cancer In Developing World; Burkina Faso ITN Distribution; Diarrhea In People Over Age Five; Gates Q&A
Researchers Highlight ‘Troubling Increase’ In Breast Cancer In Developing Countries “International cancer specialists meet this week to plan an assault on a troubling increase of breast cancer in developing countries, where nearly two-thirds of women aren’t diagnosed until it has spread through their bodies,” the Associated Press reports. Researchers will…
Also In Global Health News: Home HIV Treatment; Voluntary Testing In Kenya; Women/HIV Scorecard; Global Fund Zimbabwe Grant; Contraceptives In Tanzania
Home Vs. Clinic Treatment of HIV In Uganda The New York Times reports on a Lancet studyÂ that found treating Ugandan HIV patients at home is cheaper and just as effective as treating them in a clinic. “The finding is important because five million more Africans will need AIDS drugs in…
During a press conference on Thursday, Medecins Sans Frontieres (MSF) warned that the “global economic crisis and calls to commit funds to other health crises” threatened to undermine recent gains in the fight against HIV/AIDS, the Associated Press reports. MSF “says money for other health issues should be given in addition to money for [HIV/]AIDS” (11/5).
“As the London family planning summit looms closer, the debate begins over how much money is needed, what it should pay for and whether the fundamentally important issues of women’s reproductive rights will be addressed,” Sarah Boseley, health editor of the Guardian, writes in her “Global Health Blog.” Highlighting a new report from the Guttmacher Institute, which “assesses the scale of the unmet need for contraception,” she writes, “This report puts numbers and dollars into the frame ahead of the summit where the [Bill & Melinda Gates Foundation], [Department for International Development (DfID)], and others will be hoping big fat money pledges will be made, in the same way that the vaccines summit in London attracted massive donations — more money was raised than was hoped for.”
In this post in the Guardian’s “Poverty Matters” blog, U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin discusses a family planning summit to be held in London next month, writing the UNFPA “is supporting the initiative so that it can gain traction and support among other donors and UN member countries.” He writes, “More than 200 million women, largely in the least developed countries, want to use modern family planning methods but can’t access them,” and continues, “Enabling women to control the number and spacing of their children is essential to reducing maternal deaths.” The summit, co-hosted by the U.K. government and the Bill & Melinda Gates Foundation, “will be launched to meet this unfilled need for modern family planning in developing countries by tackling the estimated $3.6 billion (Â£2.3 billion) annual shortfall in investment (.pdf),” he adds.
“A new UNAIDS/UNDP joint issues brief [.pdf] highlights the potential impacts of free trade agreements on public health,” UNAIDS reports in a feature story on its website. “The brief concludes that ‘to retain the benefits of [flexibilities in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)], countries at a minimum should avoid entering into free trade agreements that contain obligations that can impact on pharmaceutical price or availability,'” the article states. It adds that “the potential impact of a number of current or planned free trade agreement negotiations taking place across the world — particularly affecting countries in the Asia and the Pacific region — can hinder countries’ rights to implement such flexibilities” (6/1).
“Former president George W. Bush made great strides and contributions towards improving African health during his time in office, a legacy that he continues to carry with him today,” according to a post in Malaria No More’s “Malaria Policy Center” blog. The blog highlights a recent article published by the Dallas Morning News, which…
“Millions of the world’s poorest people could have easier access to life-saving drugs if India introduces an air ticket tax to help fund purchases of cheap medicines for HIV/AIDS, malaria and tuberculosis, a senior U.N. official said,” AlertNet/Reuters reports. “UNITAID, a U.N. agency which negotiates for cheap medicines from pharmaceutical manufacturers to treat deadly diseases, is lobbying countries such as India to join its air ticket levy initiative which began in 2006,” the news service writes.